Lars Perk studied Chemistry at the University of Wageningen and obtained his PhD at the VUmc in Amsterdam. In 2008, he joined the BV Cyclotron of the VU in Amsterdam as R&D project manager. In this position, he was responsible for the development of new (mainly 18F) radiopharmaceuticals. He was also closely involved in the realization of a new manufacturing unit for radiopharmaceuticals for the VUmc. Since August 2013, he is Operational Manager at Radboud Translational Medicine. Since December 2016, he is Managing Director. He is also the coordinating radiation protection expert.